PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis (Q45012429)

8 December 2017

title

PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis (English)

1 reference

8 December 2017

5

Andreas Reichenbach

1 reference

8 December 2017

Wolfram Eichler

1

1 reference

8 December 2017

Yousef Yafai

series ordinal

2

1 reference

8 December 2017

Thurid Keller

series ordinal

3

1 reference

8 December 2017

Peter Wiedemann

series ordinal

4

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Experimental Cell Research

8 December 2017

published in

1 reference

8 December 2017

volume

299

1 reference

8 December 2017

issue

1

1 reference

8 December 2017

page(s)

68-78

1 reference

Basic Fibroblast Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Essential role of growth hormone in ischemia-induced retinal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Hypoxic regulation of vascular endothelial growth factor in retinal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

VEGF-receptor signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Angiogenesis in cancer, vascular, rheumatoid and other disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Oxygen modulates production of bFGF and TGF-beta by retinal cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Expression of thrombospondin-1 in ischemia-induced retinal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

PEDF: a multifaceted neurotrophic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

PEDF: anti-angiogenic guardian of ocular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Hypoxia: modulation of endothelial cell proliferation by soluble factors released by retinal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Effects of enhanced extracellular ammonia concentration on cultured mammalian retinal glial (Müller) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Loss of inwardly rectifying potassium currents by human retinal glial cells in diseases of the eye

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

VEGF release by retinal glia depends on both oxygen and glucose supply

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Regulation of the expression of pigment epithelium-derived factor, an anti-angiogenic factor in human oral squamous cell carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Biodegradable scleral plugs for vitreoretinal drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Intravitreal adenoviral gene transfer evokes an immune response in the retina that is directed against the heterologous lacZ transgene product but does not limit transgene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2004.05.020

1 reference

8 December 2017

1 reference